Muscular dystrophy drug rejected for use by NICE
Myasthenia gravis causes fatigue and muscle weakness, double vision, slurred speech, and difficulty with chewing, swallowing and making facial expressions."If you weigh up the cost of the drug against the hospitalisations, invasive procedures, surgeons and one-to-one care I have needed at times - I think prevention [with efgartigimod] is a cost-effective option," Mr Stephenson said."This is the first drug which has made a huge improvement and, unless you are a multimillionaire, you are not going to be able to afford to get it."
'Immense relief'
Mr Stephenson was diagnosed in 2003 when, after leaving the armed forces, he began to struggle to exercise, close his eyes or smile."Food would get stuck in my throat and I would have to reach down and pull it out," he said."When I was drinking, I was choking, and water was pouring out of my nose."You worry, 'how am I going to live like this, what am I going to do?'"The father-of-four's symptoms fitted in with a recent car crash, but physiotherapists referred him to a neurologist who tested for the condition.Mr Stephenson said: "The diagnosis was an immense relief."If you have a chronic illness, it's good to learn about it, because you're going to be stuck with it forever."Adults who took part in a trial for efgartigimod reported regaining the ability to walk daily, dress independently, and some returned to work or education."Anybody who is on the drug at the minute can stay on it, but for new patients, it's not going to be available to them."I feel so lucky to be on it," Mr Stephenson said."I feel honoured and privileged to have been on the trial."Doctors will be able to privately prescribe the drug, also known as Vyvgart, meaning patients who can pay for it will still be able to benefit.According to drug company Argenx, the price for one 400mg infusion vial is £6,569.73.The number of vials used for one infusion, which Mr Stephenson said he has fortnightly, depends on the individual.
'Disheartening message'
Andy Fletcher, chief executive of charity Muscular Dystrophy UK, said the decision not to approve the drug for NHS use "sends a disheartening message to those affected by rare and complex conditions"."Treatments are within their grasp, but their needs are not being prioritised," he said.NICE said efgartigimod was an add-on alongside other treatments, rather than a replacement.Argenx appealed against the decision on the basis that the drug is a replacement, but NICE rejected the appeal."They got ignored and that, for everybody, was so frustrating," Mr Stephenson said."Our story should've made some sort of impact, but it feels it got bypassed and overlooked."NICE said drugs like efgartigimod replace other treatments only temporarily, providing "small benefits".A spokesperson said effective and fast-acting treatments like efgartigimod would be "welcomed" by patients, given the side effects and slow-acting nature of current treatments, but NICE could not justify the cost."The cost-effectiveness estimates [for efgartigimod] are substantially above what NICE considers an acceptable use of NHS resources," they said."We know this decision will be disappointing for people living with this debilitating condition and those who care for them."Muscular Dystrophy UK said Wales and Northern Ireland tend to follow NICE guidance, meaning patients there will most likely also be affected.A separate decision process is under way in Scotland.
Listen to highlights from South Yorkshire on BBC Sounds, catch up with the latest episode of Look North
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Leader Live
2 hours ago
- Leader Live
Government turns to TikTok to highlight risks of cosmetic surgery abroad
Ministers hope the new campaign with TikTok will help people make 'more informed choices before they go under the knife'. As part of the initiative, the Government will work with medical influencers, such as Midwife Marley and Doc Tally, to create videos showing the risks of cosmetic surgery abroad. The content will urge patients to speak to a UK doctor first and avoid package holidays that include procedures. It will also include a checklist for patients to consider before they book a procedure, which includes checking the credentials of surgeons, the clinic's regulations, and understanding the aftercare. The initiative is part of a wider Government drive to tackle so-called medical tourism and ensure the NHS is not left to foot the bill when complications arise. Health minister Karin Smyth said: 'Too many people are being left with life-altering injuries after going abroad for medical procedures, without access to proper advice or safeguards. 'Often drawn in by deals too good to be true and promoted by influencers – some of whom have never been to the practice in question. 'By partnering with TikTok, we're helping people make safer, more informed choices before they go under the knife – wherever that may be.' Foreign Office minister Stephen Doughty said: 'Our aim is to explain the risks and help British people understand the actions they can take to keep themselves safe when abroad. 'If you choose to travel abroad for medical treatment, it is vital you do your research and are fully aware of the risks involved. 'We urge anyone considering a medical procedure abroad to review our travel advice, relevant guidance from the NHS and other professional bodies, and research foreign providers thoroughly to ensure they meet the highest standard of care. 'Informed choices today can help avoid serious complications tomorrow.' The initiative comes after ministers outlined plans to cut down on 'cowboy' cosmetic procedures by introducing new restrictions. Earlier this month, the Department of Health and Social Care unveiled proposals which include only allowing 'suitably qualified' and Care Quality Commission-regulated health workers to deliver high-risk procedures such as Brazilian butt lifts. Elsewhere, clinics offering Botox and fillers will need licences, and age restrictions will be introduced to prevent children from trying to follow 'dangerous beauty trends on social media'. Those who break the rules will face sanctions, including financial penalties, officials said.
Leader Live
2 hours ago
- Leader Live
Baroness Amos to lead NHS maternity and neonatal investigation
Baroness Amos was selected by Health Secretary Wes Streeting after bereaved families expressed a preference for someone with distance from the NHS who is able to bring a fresh pair of eyes to the role, the Department of Health and Social Care (DHSC) said. Mr Streeting has been meeting bereaved and harmed families who have been let down by maternity and neonatal services across the country, including in some of the worst affected trusts, DHSC added. In June, he announced that a national investigation into 'systemic' failures in NHS maternity care had been launched by the Government after families were 'gaslit' in their search for the truth. Baroness Amos is master of University College, Oxford, and was a UK Government minister and a senior official at the United Nations. Mr Streeting said: 'I have been appalled by the many harrowing stories I've heard from mothers and fathers let down by the NHS. 'Families asked for fresh eyes, independence and compassion – and that's why I've appointed Baroness Amos. Valerie has an outstanding record of leadership and driving change, nationally and internationally. She will work closely with families to uncover the truth, confront problems and drive the improvements needed so every woman and baby receives safe, high-quality care. 'Through our Plan for Change, we will rebuild the NHS to ensure no family suffers like this again.' Baroness Amos said: 'I will carry the weight of the loss suffered by families with me throughout this investigation. I hope that we will be able to provide the answers that families are seeking and support the NHS in identifying areas of care requiring urgent reform.' The investigation will look at up to 10 services in the country. It will also review the maternity and neonatal system, bringing together the findings of past reviews into one national set of actions, the DHSC said. It will begin work this summer and produce an initial set of national recommendations by December. The 10 maternity and neonatal units will be decided by Baroness Amos and her team, alongside the terms of reference of the investigation, which are being developed with families who have experiences of maternity and neonatal care, including in Leeds, Sussex and Nottingham, the DHSC added. The investigation is separate from the National Maternity and Neonatal Taskforce, which will be made up of a panel of experts and families, and chaired by Mr Streeting. Gill Walton, chief executive of the RCM, said: 'We are pleased to hear of the appointment of Baroness Amos as chair of the rapid review. She has a reputation for taking a thoughtful and strategic approach and we welcome her fresh insight into maternity and neonatal safety. 'It is absolutely vital, though, that this review gets under way quickly. When he announced it in June, we welcomed Wes Streeting's commitment to publishing the review by Christmas, a promise he repeated at the Progress in Partnership summit on maternity and neonatal safety last month. 'However, we are already halfway through August, with no terms of reference, no sense of the trusts who are likely to be part of the review or no clarity on how the review will be conducted. 'Every woman and family should leave maternity and neonatal services whole, happy and healthy, and every member of maternity staff should start and end their shift knowing they have provided safe, good-quality care. 'At the moment, that simply isn't the case. Previous reviews and countless Care Quality Commission reports have flagged the same the systemic failings that are at the heart of the issues facing maternity and neonatal care issues time and time again: unsafe staffing, poor workplace cultures, and not listening to women. 'In spite of that, there has been no forward movement. Wes Streeting promised to change that. Thousands of midwives and maternity support workers, and the whole of the maternity community, are desperate for him to keep that promise and deliver the change we all want to see.' The RCM has also urged the review to look at examples of good maternity care, as well as where services are not meeting standards of care.
North Wales Chronicle
2 hours ago
- North Wales Chronicle
Government turns to TikTok to highlight risks of cosmetic surgery abroad
Ministers hope the new campaign with TikTok will help people make 'more informed choices before they go under the knife'. As part of the initiative, the Government will work with medical influencers, such as Midwife Marley and Doc Tally, to create videos showing the risks of cosmetic surgery abroad. The content will urge patients to speak to a UK doctor first and avoid package holidays that include procedures. It will also include a checklist for patients to consider before they book a procedure, which includes checking the credentials of surgeons, the clinic's regulations, and understanding the aftercare. The initiative is part of a wider Government drive to tackle so-called medical tourism and ensure the NHS is not left to foot the bill when complications arise. Health minister Karin Smyth said: 'Too many people are being left with life-altering injuries after going abroad for medical procedures, without access to proper advice or safeguards. 'Often drawn in by deals too good to be true and promoted by influencers – some of whom have never been to the practice in question. 'By partnering with TikTok, we're helping people make safer, more informed choices before they go under the knife – wherever that may be.' Foreign Office minister Stephen Doughty said: 'Our aim is to explain the risks and help British people understand the actions they can take to keep themselves safe when abroad. 'If you choose to travel abroad for medical treatment, it is vital you do your research and are fully aware of the risks involved. 'We urge anyone considering a medical procedure abroad to review our travel advice, relevant guidance from the NHS and other professional bodies, and research foreign providers thoroughly to ensure they meet the highest standard of care. 'Informed choices today can help avoid serious complications tomorrow.' The initiative comes after ministers outlined plans to cut down on 'cowboy' cosmetic procedures by introducing new restrictions. Earlier this month, the Department of Health and Social Care unveiled proposals which include only allowing 'suitably qualified' and Care Quality Commission-regulated health workers to deliver high-risk procedures such as Brazilian butt lifts. Elsewhere, clinics offering Botox and fillers will need licences, and age restrictions will be introduced to prevent children from trying to follow 'dangerous beauty trends on social media'. Those who break the rules will face sanctions, including financial penalties, officials said.
